| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 23.0× | −1.7× | |
| Price / Book | 7.6× | 2.0× | |
| Price / Sales | 6.5× | 3.9× | |
| Price / Free cash flow | 31.3× | −1.6× | |
| EV / EBITDA | 15.7× | −1.2× | |
| Earnings yield | 4.4% | −14.6% | |
| Free cash flow yield | 3.2% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,252.04 | −0.40% | $1.18T | 57.3× | 77.8% | +16.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $284.43 | −0.35% | $502.62B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $404.64 | +0.80% | $363.2B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.29 | −1.14% | $355.99B | 19.7× | 34.7% | +73.5% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.52 | −0.07% | $278.44B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $164.85 | −0.34% | $255.67B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $679.93 | −1.46% | $251.4B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $428.12 | −1.01% | $231.45B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $154.48 | −1.09% | $191.55B | 22.8× | 37.5% | +32.0% |
ABNYSE:ABTAbbott Laboratories · 🇺🇸 NYSE | $104.39 | −0.48% | $181.83B | 28.0× | 12.5% | −19.0% |
